BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18792900)

  • 1. Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: Correlation with progression and prognosis.
    Ghosh S; Ghosh A; Maiti GP; Alam N; Roy A; Roy B; Roychoudhury S; Panda CK
    Int J Cancer; 2008 Dec; 123(11):2594-604. PubMed ID: 18792900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential transmission of the molecular signature of RBSP3, LIMD1 and CDC25A in basal/ parabasal versus spinous of normal epithelium during head and neck tumorigenesis: A mechanistic study.
    Sarkar S; Alam N; Mandal SS; Chatterjee K; Ghosh S; Roychoudhury S; Panda CK
    PLoS One; 2018; 13(4):e0195937. PubMed ID: 29672635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of RASSF1A in premalignant cervical lesions: clinical and prognostic significance.
    Mitra S; Mazumder Indra D; Basu PS; Mondal RK; Roy A; Roychoudhury S; Panda CK
    Mol Carcinog; 2012 Sep; 51(9):723-33. PubMed ID: 21809394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIMD1 is more frequently altered than RB1 in head and neck squamous cell carcinoma: clinical and prognostic implications.
    Ghosh S; Ghosh A; Maiti GP; Mukherjee N; Dutta S; Roy A; Roychoudhury S; Panda CK
    Mol Cancer; 2010 Mar; 9():58. PubMed ID: 20226061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit.
    Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Alam N; Sikdar N; Roy B; Roychoudhury S; Panda CK
    J Pathol; 2009 Feb; 217(3):408-19. PubMed ID: 19023882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of EGFR in head and neck squamous cell carcinoma is associated with inactivation of SH3GL2 and CDC25A genes.
    Maiti GP; Mondal P; Mukherjee N; Ghosh A; Ghosh S; Dey S; Chakrabarty J; Roy A; Biswas J; Roychoudhury S; Panda CK
    PLoS One; 2013; 8(5):e63440. PubMed ID: 23675485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
    Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of FANCC and PTCH1 with the development of early dysplastic lesions of the head and neck.
    Ghosh A; Ghosh S; Maiti GP; Mukherjee S; Mukherjee N; Chakraborty J; Roy A; Roychoudhury S; Panda CK
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S528-38. PubMed ID: 21861228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
    Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
    Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
    Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
    Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
    Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of ROBO1/DUTT1 and ROBO2 loci in early dysplastic lesions of head and neck: clinical and prognostic implications.
    Ghosh S; Ghosh A; Maiti GP; Alam N; Roy A; Roychoudhury S; Panda CK
    Hum Genet; 2009 Mar; 125(2):189-98. PubMed ID: 19104841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance.
    Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Zabarovsky ER; Roy A; Roychoudhury S; Panda CK
    Cancer Sci; 2010 Jun; 101(6):1511-20. PubMed ID: 20412120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of deletion in the chromosomal 8p21.3-23 region with the development of invasive head & neck squamous cell carcinoma in Indian patients.
    Bhattacharya N; Tripathi A; Dasgupta S; Sabbir MG; Roy A; Sengupta A; Roy B; Roychowdhury S; Panda CK
    Indian J Med Res; 2003 Aug; 118():77-85. PubMed ID: 14680203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
    Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential allelic deletion of RBSP3, LIMD1 and CDC25A in head and neck squamous cell carcinoma: Implication in cancer screening and early detection.
    Sarkar S; Panda CK
    Cancer Biol Ther; 2018 Jul; 19(7):631-635. PubMed ID: 29624473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
    Zhang J; Ling T; Wu H; Wang K
    J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC gene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients.
    Bhattacharya N; Roy A; Roy B; Roychoudhury S; Panda CK
    J Oral Pathol Med; 2009 Nov; 38(10):759-63. PubMed ID: 19453846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of RASSF1A in head and neck cancer.
    Dong SM; Sun DI; Benoit NE; Kuzmin I; Lerman MI; Sidransky D
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3635-40. PubMed ID: 14506151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.